👇Ref (open access): https://t.co/dalBsOnLBw https://t.co/GqLDnm9bR5
1,734 followers
1,734 followers
I was expecting an announcement from $ALXO on a new SIRPa Ab asset based on this recent publication👇. The collab w/ Tallac is more differentiated though so I like it, but probably a bit more risky. #CD47 science is cool! https://t.co/dalBsOFmt4
1,734 followers
@SubBasepair_Res My earlier tweet is best data I found implicating competition for Fc receptors. /2 https://t.co/wXlkDPsRYh
1,734 followers
This is how IgG subclass influences the efficacy of anti-SIRPα antagonist antibodies in an in vitro phagocytosis experiment. Care of $alxo. Implications for $tril $sttk and #CD47 as a therapeutic target. https://t.co/dalBsOnLBw https://t.co/wdFWYGyaC8